Asia Clinical Trials Outsourcing Congress (ACTOC11)
|Event Date/Time: Sep 19, 2011||End Date/Time: Sep 20, 2011|
|Registration Date: Sep 09, 2011|
|Early Registration Date: May 31, 2011|
By streamlining their regulatory approval processes Singapore can often provide approval in as little as six weeks, Taiwan in 8 â€“ 10 weeks and in the case of Korea the Korea Food and Drug Administration (KFDA) can deliver approval within 30 working days. In India huge steps have been taken over the past few years to streamline the approval process with average approval times now down to between 12-16 weeks. This early approval represents huge saving when contrasted against China where regulatory approval can often take between 9 â€“ 12 months.
As a result of this Western companies have established increasingly successful alliances with both academic and commercial organizations in these regions especially in the light of recently improved IP protection legislation and increasing satisfaction with the quality of clinical data provided by clinical trial sites,
Whilst these factors make conducting clinical trials in Asia evermore attractive and can translate into huge potential cost savings for Western companies this must be also be contrasted against the need for ongoing investment in training and monitoring of support systems to ensure data quality and management.
The Asia Clinical Trials Outsourcing Congress will examine the feasibility and challenges of conducting clinical trials in these emerging countries through a series of keynote presentations from an expert international speaker panel, interactive panel and roundtables discussions.
Topics under discussion include:
- Establishing a framework for evaluating outsourcing destinations in Asia
- Building a robust infrastructure and processes to conduct clinical trials in Asia
- Operating and delivering successful clinical trials in India
- Protecting pharma patents in Asia
- Case Study: Running early phase clinical trials in Korea
- Overview of regulatory and operational considerations of conducting clinical trials in the Philippines
- Data standardisation in multi-centre data management in Asia
- Optimizing clinical trial supply and distribution logistics in Asia
- Strategies for successful patient recruitment and retention in Asia
- Best practice global data quality control
In addition to presentations from our international speaker panel there will also be interactive panel discussions and round tables.
This Congress will be co-located with the 3rd China Clinical Trials Outsourcing Congress and attracted over 50 senior-level delegates in the first week of launch. There are opportunities to exhibit in the centralised exhibition area, sponsor or to have one to one prearranged meetings. Post conference workshops on topics of your choice are also available
For further information please contact Steve Hambrook, Conference Director, on +44 (0) 7949 400917 or by email: firstname.lastname@example.org